Diefenbach-Elstob, Tanya, Guernier, Vanina, Burgess, Graham, Pelowa, Daniel, Dowi, Robert, Gula, Bisato, Puri, Munish, Pomat, William, McBryde, Emma, Plummer, David, Rush, Catherine, and Warner, Jeffrey (2019) Molecular evidence of drug-resistant tuberculosis in the Balimo region of Papua New Guinea. Tropical Medicine and Infectious Disease, 4 (1). 33.

Preview

PDF (Published Version) - Published Version Available under License Creative Commons Attribution. Download (313kB) | Preview

 

3

918

Abstract

Papua New Guinea (PNG) has a high burden of tuberculosis (TB), including drugresistant TB (DR-TB). DR-TB has been identified in patients in Western Province, although there has been limited study outside the provincial capital of Daru. This study focuses on the Balimo region of Western Province, aiming to identify the proportion of DR-TB, and characterise Mycobacterium tuberculosis (MTB) drug resistance-associated gene mutations. Sputum samples were investigated for MTB infection using published molecular methods. DNA from MTB-positive samples was amplified and sequenced, targeting the rpoB and katG genes to identify mutations associated with rifampicin and isoniazid resistance respectively. A total of 240 sputum samples were collected at Balimo District Hospital (BDH). Of these, 86 were classified as positive based on the results of the molecular assays. For samples where rpoB sequencing was successful, 10.0% (5/50, 95% CI 4.4–21.4%) were considered rifampicin-resistant through detection of drug resistance-associated mutations. We have identified high rates of presumptive DR-TB in the Balimo region of Western Province, PNG. These results emphasise the importance of further surveillance, and strengthening of diagnostic and treatment services at BDH and throughout Western Province, to facilitate detection and treatment of DR-TB, and limit transmission in this setting.

Actions (Repository Staff Only)

Item Control Page